ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,302,201 | -25.3% | 48,463 | -0.9% | 0.00% | -33.3% |
| Q2 2023 | $1,743,168 | +36.1% | 48,883 | -3.0% | 0.00% | +50.0% |
| Q1 2023 | $1,280,389 | -39.9% | 50,409 | -4.0% | 0.00% | -50.0% |
| Q4 2022 | $2,130,658 | +22.7% | 52,531 | -0.1% | 0.00% | +33.3% |
| Q3 2022 | $1,737,000 | -7.9% | 52,561 | -1.8% | 0.00% | 0.0% |
| Q2 2022 | $1,885,000 | -24.4% | 53,518 | -1.2% | 0.00% | -25.0% |
| Q1 2022 | $2,492,000 | -29.6% | 54,186 | +1.5% | 0.00% | -20.0% |
| Q4 2021 | $3,538,000 | – | 53,373 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
| L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
| Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
| Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
| ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
| First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
| Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
| Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
| Tygh Capital Management, Inc. | 63,947 | $4,240,000 | 0.60% |